AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | -11.94% |
| Q3 2025 | -12.60% |
| Q2 2025 | -6.49% |
| Q1 2025 | -10.92% |
| Q4 2024 | -6.77% |
| Q3 2024 | -10.91% |
| Q2 2024 | -11.25% |
| Q1 2024 | -11.39% |
| Q4 2023 | -22.61% |
| Q3 2023 | 20.38% |
| Q2 2023 | 5.75% |
| Q1 2023 | -13.40% |
| Q4 2022 | -9.92% |
| Q3 2022 | -9.30% |
| Q2 2022 | -0.96% |
| Q1 2022 | 77.99% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 0.00% |